Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
San Francisco, CA
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Denver, CO
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Washington,
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Fort Lauderdale, FL
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Orlando, FL
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Santa Fe, NM
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Santa Fe, NM
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Charlotte, NC
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Dallas, TX
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated:  12/14/2017
GSK Investigational Site
mi
from
Lyon cedex 04,
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
A Phase IIb Study to Select a Once Daily Dose of GSK1349572 Administered With Either Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Status: Enrolling
Updated: 12/14/2017
GSK Investigational Site
mi
from
Lyon cedex 04,
Click here to add this to my saved trials
Phase 1 Safety and Immunogenicity of Meningococcal Vaccine
Ph 1 Dose-Escalation Study of Safety and Immunogenicity of 3 Injections, at 0, 6, 2 Wks, of Group B Meningococcal 8570 HOPS-G NOMV Vaccine Adm Intramuscularly to Healthy Subjects at 10, 25, 50, 75 μg With Adjuvant
Status: Enrolling
Updated:  12/15/2017
Clinical Trials Center, WRAIR
mi
from
Silver Spring, MD
Phase 1 Safety and Immunogenicity of Meningococcal Vaccine
Ph 1 Dose-Escalation Study of Safety and Immunogenicity of 3 Injections, at 0, 6, 2 Wks, of Group B Meningococcal 8570 HOPS-G NOMV Vaccine Adm Intramuscularly to Healthy Subjects at 10, 25, 50, 75 μg With Adjuvant
Status: Enrolling
Updated: 12/15/2017
Clinical Trials Center, WRAIR
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
St. Vincents East
mi
from
Birmingham, AL
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
St. Vincents East
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
Christianna Care Health System
mi
from
Newark, DE
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
Christianna Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
University of Kentucky Medical Center
mi
from
Lexington, KY
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
Ochsner
mi
from
New Orleans, LA
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
Cape Fear valley Hospital
mi
from
Fayetteville, NC
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
Cape Fear valley Hospital
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
Medcentral Hospital
mi
from
Mansfield, OH
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
Medcentral Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
Methodist Hospital
mi
from
Houston, TX
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated:  12/18/2017
Waukesha Medical Center
mi
from
West Allis, WI
Multicenter Infection Surveillance Study Following Open Heart Surgery
Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures
Status: Enrolling
Updated: 12/18/2017
Waukesha Medical Center
mi
from
West Allis, WI
Click here to add this to my saved trials
TDAP Safety in Pregnant Women
Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women
Status: Enrolling
Updated:  12/18/2017
Duke University Dept of ObGyn, Division of Maternal-Fetal Medicine
mi
from
Durham, NC
TDAP Safety in Pregnant Women
Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women
Status: Enrolling
Updated: 12/18/2017
Duke University Dept of ObGyn, Division of Maternal-Fetal Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
TDAP Safety in Pregnant Women
Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women
Status: Enrolling
Updated:  12/18/2017
Vanderbilt Medical Center, Vaccine Research Program
mi
from
Nashville, TN
TDAP Safety in Pregnant Women
Clinical Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) Safety in Pregnant Women
Status: Enrolling
Updated: 12/18/2017
Vanderbilt Medical Center, Vaccine Research Program
mi
from
Nashville, TN
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Lombardi Comprehensive Cancer Center at Georgetown University
mi
from
Washington,
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Lombardi Comprehensive Cancer Center at Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Boston Med Ctr
mi
from
Boston, MA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Montefiore Medical Center
mi
from
Bronx, NY
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Pennsylvania Oncology Hematology Associates
mi
from
Philadelphia, PA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Pennsylvania Oncology Hematology Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated:  12/19/2017
Benaroya Research Institute at Virginia Mason
mi
from
Seattle, WA
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
Status: Enrolling
Updated: 12/19/2017
Benaroya Research Institute at Virginia Mason
mi
from
Seattle, WA
Click here to add this to my saved trials
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
Status: Enrolling
Updated:  12/19/2017
Personal Health Clinic UAB
mi
from
Birmingham, AL
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
Status: Enrolling
Updated: 12/19/2017
Personal Health Clinic UAB
mi
from
Birmingham, AL
Click here to add this to my saved trials
Reducing Delay of Vaccination in Children Study
Reducing Delay of Vaccination in Children Study
Status: Enrolling
Updated:  12/19/2017
Kaiser Permanente of Colorado
mi
from
Denver, CO
Reducing Delay of Vaccination in Children Study
Reducing Delay of Vaccination in Children Study
Status: Enrolling
Updated: 12/19/2017
Kaiser Permanente of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated:  12/19/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated: 12/19/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated:  12/19/2017
Children's Mercy Hospitals and Clinics
mi
from
Kansas City, MO
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated: 12/19/2017
Children's Mercy Hospitals and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated:  12/19/2017
University of Texas Southwestern
mi
from
Dallas, TX
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection
Status: Enrolling
Updated: 12/19/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Duarte, CA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Duarte, CA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
San Francisco, CA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Aurora, CO
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Aurora, CO
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Westwood, KA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Westwood, KA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Lexington, KY
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Boston, MA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Boston, MA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Boston, MA
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Detroit, MI
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Minnesota, MN
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Minnesota, MN
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Rochester, MN
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Hackensack, NJ
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
New York, NY
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Syracuse, NY
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Syracuse, NY
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated:  12/20/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials